The Gerlach lab is dedicated to understanding diversification within CD8+ T cell responses with the long-term goal to improve immunotherapy and vaccination. Recent work bridges murine and human immunology to facilitate cross-species translation of findings. We provide an easy-to-use strategy to obtain fine-graded information on T cell functional and migratory capacities that identifies cells of the same properties in mice and humans (Zwijnenburg et al. Immunity 2023 | Pokharel & Shryki et al. Eur J Immunol 2024).
We’re currently recruiting a SCIENTIST / POSTDOC and a technician in Regensburg.
SCIENTIST / POSTDOC
One lab – two locations
Stockholm, Sweden – Karolinska Institutet.
Regensburg, Germany – Leibniz Institute of Immunotherapy (LIT) & University of Regensburg.
